Showing results (1-10 of 205) with videos related to
Sort By:
Pageof 21
Clinical Lymphoma & Myeloma|December 17, 2008
Optimizing chemotherapeutic strategies for peripheral T-cell lymphomasLori J Rosenstein, Brian K LinkBest Practice & Research. Clinical Haematology|February 18, 2018
Transformation of follicular lymphoma - Why does it happen and can it be prevented?Brian K LinkCurrent Hematologic Malignancy Reports|April 29, 2010
Do recent reports of prolonged survival in patients with follicular lymphoma suggest that deferral of therapy is no longer justifiable?Brian K LinkLeukemia & Lymphoma|December 23, 2014
Relationships between chemotherapy, chemotherapy dose intensity and outcomes of follicular lymphoma in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic Lymphoma Specialized Program of Research Excellence Molecular Epidemiology ResourceKitsada Wudhikarn, Brian J Smith, Anna M Button, et al.Advances in Hematology|June 21, 2011
Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin LymphomaBhanu Vakkalanka, Brian K LinkJournal of Comparative Effectiveness Research|December 19, 2013
Comparative effectiveness research in follicular lymphoma: current and future perspectives and challengesKitsada Wudhikarn, Brian K LinkTherapeutic Advances in Hematology|February 6, 2019
Novel treatment approaches and future perspectives in follicular lymphomaGrerk Sutamtewagul, Brian K LinkExpert Review of Anticancer Therapy|March 23, 2011
Chemotherapy and antibody combinations for relapsed/refractory non-Hodgkin's lymphomaAhmad S Halwani, Brian K LinkSeminars in Oncology|February 1, 2017
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)John P Leonard, Brian K LinkExpert Opinion on Biological Therapy|March 10, 2004
Monoclonal antibody therapy of B cell lymphomaGeorge J Weiner, Brian K LinkPageof 21